Andreas Busch serves as Executive at Cyclerion Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Andreas Busch has executed 6 insider transactions totaling $695.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 14, 2025 involved selling 3,092 shares valued at $11.4K.
Andreas Busch currently holds 324,172 shares of Cyclerion Therapeutics, Inc. (CYCN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andreas Busch has been a net buyer of CYCN stock. They have purchased $695.8K and sold $0 worth of shares.
Andreas Busch's most recent insider trade was on Oct 14, 2025, when they sold 3,092 shares at $3.68 per share.
Get notified when new Form 4 filings are submitted
| $3.04 |
| Discretionary |
| Feb 1, 2024 | ABSI | $0 | Award | 83,125 | $N/A | Discretionary |
| Oct 12, 2023 | ABSI | $0 | Award | 175,000 | $N/A | Discretionary |
| Nov 9, 2020 | CYCN | $316.3K | Purchase | 125,000 | $2.53 | Discretionary |
| Nov 15, 2019 | CYCN | $227.5K | Purchase | 125,000 | $1.82 | Discretionary |